These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 9708845)

  • 21. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
    Denney CB
    J Clin Child Psychol; 2001 Mar; 30(1):98-109. PubMed ID: 11294083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD).
    Retz W; Retz-Junginger P
    Eur Arch Psychiatry Clin Neurosci; 2014 Nov; 264 Suppl 1():S35-43. PubMed ID: 25231833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
    't Jong GW; van den Anker JN
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263
    [No Abstract]   [Full Text] [Related]  

  • 25. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM; Coghill DR; Matthews K
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Stimulant and non-stimulant medication in current and future therapy for ADHD].
    Franke AG; Konrad A; Lieb K; Huss M
    Fortschr Neurol Psychiatr; 2012 Mar; 80(3):130-40. PubMed ID: 21611939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
    Nolan EE; Gadow KD; Sprafkin J
    Pediatrics; 1999 Apr; 103(4 Pt 1):730-7. PubMed ID: 10103294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.
    Varley CK
    Psychopharmacol Bull; 1985; 21(2):216-21. PubMed ID: 2860692
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children.
    Kociancic T; Reed MD; Findling RL
    Expert Opin Drug Saf; 2004 Mar; 3(2):93-100. PubMed ID: 15006715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.
    Contini V; Rovaris DL; Victor MM; Grevet EH; Rohde LA; Bau CH
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):555-60. PubMed ID: 22709890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder.
    Prehn-Kristensen A; Krauel K; Hinrichs H; Fischer J; Malecki U; Schuetze H; Wolff S; Jansen O; Duezel E; Baving L
    Brain Res; 2011 May; 1388():56-68. PubMed ID: 21385569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulants: Therapeutic actions in ADHD.
    Arnsten AF
    Neuropsychopharmacology; 2006 Nov; 31(11):2376-83. PubMed ID: 16855530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder.
    Schweren LJ; de Zeeuw P; Durston S
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1151-64. PubMed ID: 23165220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An update on attention deficit disorder.
    Harv Ment Health Lett; 2004 May; 20(11):4-7. PubMed ID: 15153391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.